Search

Author/Creator Roden, Jennifer E.

1. A phase I study of pulse high‐dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma. (29th January 2013)

Authors:
Budde, Lihua E.; Zhang, Michelle M.; Shustov, Andrei R.; Pagel, John M.; Gooley, Ted A.; Oliveira, George R.; Chen, Tara L.; Knudsen, Nancy L.; Roden, Jennifer E.; Kammerer, Britt E.; Frayo, Shani L.; Warr, Thomas A.; Boyd, Thomas E.; Press, Oliver W.; Gopal, Ajay K.
Journal:
British journal of haematology
Issue:
Volume 161:Number 2(2013:Apr.)
Page Start:
183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. (14th September 2018)

Authors:
Budde, Lihua E.; Wu, David; Martin, Daniel B.; Philip, Mary; Shustov, Andrei R.; Smith, Stephen D.; Gooley, Ted A.; Chen, Tara L.; Libby, Edward N.; Chen, Eric Y.; Kojouri, Kiarash; Langerak, Alan; Roden, Jennifer E.; Press, Oliver W.; Gopal, Ajay K.
Journal:
British journal of haematology
Issue:
Volume 183:Number 4(2018)
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Brentuximab vedotin administered to platinum‐refractory, transplant‐naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status. Issue 4 (18th September 2014)

Authors:
Onishi, Maika; Graf, Solomon A.; Holmberg, Leona; Behnia, Sanaz; Shustov, Andrei R.; Schiavo, Karen; Philip, Mary; Libby, Edward N.; Cassaday, Ryan D.; Pagel, John M.; Roden, Jennifer E.; Maloney, David G.; Green, Damian J.; Till, Brian G.; Press, Oliver W.; Smith, Stephen D.; Gopal, Ajay K.
Journal:
Hematological oncology
Issue:
Volume 33:Issue 4(2015:Dec.)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Results of a phase I‐II study of fenretinide and rituximab for patients with indolent B‐cell lymphoma and mantle cell lymphoma. (5th January 2017)

Authors:
Cowan, Andrew J.; Stevenson, Phillip A.; Gooley, Ted A.; Frayo, Shani L.; Oliveira, George R.; Smith, Stephen D.; Green, Damian J.; Roden, Jennifer E.; Pagel, John M.; Wood, Brent L.; Press, Oliver W.; Gopal, Ajay K.
Journal:
British journal of haematology
Issue:
Volume 176:Number 4(2017)
Page Start:
583
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗